EpiHealth: Epidemiology for Health
8081 – 8090 of 10061
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Phase I, Randomized, Double-Blind, Placebo-Controlled, Multiple Intravenous, Dose-Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Last Suicide Attempt before Completed Suicide in Severe Depression: An Extended Suicidal Process May Be Found in Men Rather Than Women.
(
- Contribution to journal › Article
-
Mark
Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in early rheumatoid arthritis: 2-year quality-of-life results of the randomised, controlled, SWEFOT trial.
(
- Contribution to journal › Article
-
Mark
miQ - a novel microRNA based diagnostic and prognostic tool for prostate cancer.
(
- Contribution to journal › Article
-
Mark
Limiting factors for liver regeneration after a major hepatic resection for colorectal cancer metastases.
(
- Contribution to journal › Article
-
Mark
Former Male Elite Athletes Have Lower Incidence of Fragility Fractures than Expected.
(
- Contribution to journal › Article
-
Mark
Predicting Changes in Cardiovascular Risk Factors in Type 2 Diabetes in the Post-UKPDS Era: Longitudinal Analysis of the Swedish National Diabetes Register.
(
- Contribution to journal › Article
-
Mark
Breast Cancer in Systemic Lupus Erythematosus
(
- Contribution to journal › Article
-
Mark
Dabigatran in clinical practice - One-year experience at Skåne University Hospital.
(
- Contribution to journal › Letter
-
Mark
Tenascin-C levels in synovial fluid are elevated after injury to the human and canine joint and correlate with markers of inflammation and matrix degradation
(
- Contribution to journal › Article